［1］ Jacobs JW，Lund PK，Potts Jr Jt，et al.Procalcitonin is a glycoprotein［J］.J Biol Chem,1981,256(6):2803-2807.
［2］ LIN L,SUN XF,TAN XL,et al.The value of serum procalcitonin (PCT) in identifying the cause of fever in patients with cancer［J］.Practical Journal of Cancer,2009,24(01):48-51.［林琳,孙晓非,谭肖鹂,等.血清降钙素原(PCT)鉴别肿瘤患者发热原因的价值探讨［J］.实用癌症杂志,2009,24(01):48-51.］
［3］ Assicot M，Gendrel D，Carsin H，et al.High serum procalcitonin concentration in patients with sepsi and infection ［J］.Lancet，1993,341(8844):515-518.
［4］ Maruna P，Nedelnikova K，Gurlieh R．Physiology and genetics of procaleitonin［J］．Physiol Res，2000,49(Suppl)：57-61．
［5］ Whang KT,Vath SD,Becket KL,et al.Procalcitonin and prointlammatory eytokine interactions in sepsis［J］．Shock，2000，14 (1)：73-78．
［6］ Dandona P,Nix D,Wilson MF,et al.Procalcitonin increase after endotoxin injection in normal subjects［J］.J Clin Endocrinol Metab,1994,79(6):1605-1608.
［7］ Procalcitonin emergency clinical application expert consensus group.Procalcitonin (PCT) emergency.Expert consensus on clinical application［J］.Chinese Journal of Emergency Medicine,2012,21(9):944-951.［降钙素原急诊临床应用专家共识组.降钙素原（PCT）急诊临床应用的专家共识［J］.中华急诊医学杂志,2012,21(9):944-951.］
［8］ DING H,ZHU XC,CHI JY,et al.The value of NAP,PCT and hs-CRP detection in identifying infection types［J］.Laboratory Medicine,2017,32(10):894-897.［丁红,朱星成,迟锦瑜,等.NAP、PCT、hs-CRP检测在鉴别感染类型中的价值［J］.检验医学,2017,32(10):894-897.］
［9］ Guo SY,Zhou Y,Hu QF,et al.Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis［J］.American Journal of the Medical Sciences,2015,349(6):499-504.
［10］ Brutsaert EF,Gersten AJ,Tassler AB,et al.Medullary thyroid cancer with undetectable serum calcitonin［J］.Journal of Clinical Endocrinology & Metabolism,2015,100(2):337-41.
［11］ Bugalho MJ,Madureira D,Domingues R,et al.Medullary thyroid carcinoma preferentially secreting procalcitonin［J］.Thyroid,2014,24(7):1190-1191.
［12］ Kaczka K,Mikosiński S,Fendler W,et al.Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection［J］.Advances in Clinical & Experimental Medicine,2012,21(2):169-178.
［13］ Machens A,Lorenz K,Dralle H.Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer［J］.Journal of Clinical Endocrinology & Metabolism,2014,99(8):2986-2994.
［14］ Cate CC,Pettengill OS,Sorenson GD.Biosynthesis of procalcitonin in small cell carcinoma of the lung［J］.Cancer Res 1986,46(2):812-818.
［15］ M Patout,M Salaün,V Brunel,et al.Thiberville.Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers［J］.Clinical Biochemistry,2014,47(18):263-267.
［16］ Avrillon V,Locatellisanchez M,Folliet L,et al.Lung cancer may increase serum procalcitonin level［J］.Infectious Disorders - Drug Targets(Formerly Current Drug Targets - Infectious,2015,15(1):57-63.
［17］ Hagiya H,Matsui T,Kitamura T,et al.Pancreatic neuroendocrine tumor abnormally secreting procalcitonin［J］.Pancreas,2017,46(1):e7-e9.
［18］ Chen L,Zhang Y,Lin Y,et al.The role of elevated serum procalcitonin in neuroendocrine neoplasms of digestive system［J］.Clinical Biochemistry,2017,50(18):982-987.
［19］ YE Q,CHEN Y,LUO LQ,et al.The value of serum procalcitonin and C-reactive protein in identifying the cause of fever in cancer patients［J］.International Journal of Laboratory Medicine,2014,35(19):2604-2606.［叶倩，陈燕，罗玲清，等.血清降钙素原及C反应蛋白在鉴别肿瘤患者发热原因中的价值［J］.国际检验医学杂志,2014,35(19):2604-2606.］
［20］ CHEN YK,DENG H,CAI SN,et al.Clinical study on early diagnosis of infection and tumor heat in patients with advanced tumors［J］.Chinese Journal of Nosocomiology,2016,26(12):2721-2723.［陈银葵，邓欢，蔡思娜，等.肿瘤晚期患者感染与肿瘤热早期诊断的临床研究［J］.中华医院感染学杂志,2016,26(12):2721-2723.］
［21］ Zhao Z，Li X，Zhao Y，et al.Role of C-reactive protein and procalcitonin in discriminating between infectious fever and tumor fever in non-neutropenic lung cancer patients［J］.Medicine(Baltimore),2018,97(33):e11930.
［22］ GUO F,HUO YS,FENG M,et al.Study of procalcitonin in the diagnosis of fever in patients with malignant tumors［J］.International Journal of Laboratory Medicine,2017,38(9):1186-1189.［郭凡,霍怡杉,封敏,等.降钙素原在恶性肿瘤患者发热诊断中的研究［J］.国际检验医学杂志,2017,38(9):1186-1189.］
［23］ ZHANG JY,YU Z,JIA L,et al.Clinical value of procalcitonin in the differential diagnosis of bacterial bloodstream infection in patients with cancer［J］.Chinese Journal of Nosocomiology,2017,27(2):288-291.［张静雅,于珍,贾丽,等.降钙素原在肿瘤患者细菌血流感染鉴别中的临床价值研究［J］.中华医院感染学杂志,2017,27(2):288-291.］
［24］ Vincenzi B,Fioroni I,Pantano F,et al.Procalcitonin as diagnostic marker of infection in solid tumors patients with fever［J］.Scientific Reports,2016(6):28090.
［25］ LU YJ,LU S.Application of procalcitonin in patients with non-neutrophilic tumor fever［J］.Chinese Contemporary Medicine,2013,20(15):51-52.［陆粤就,陆森.降钙素原在非中性粒细胞减少肿瘤发热患者中的应用研究［J］.中国当代医药,2013,20(15):51-52.］
［26］ ZHANG LP.The value of serum procalcitonin detection in the diagnosis of neutropenia with infection after solid tumor chemotherapy［J］.Journal of Clinical Medicine in Practice,2014,18(15):187-189.［张丽萍.血清降钙素原检测在实体瘤化疗后粒细胞减少伴感染诊断中的价值［J］.实用临床医药杂志,2014,18(15):187-189.］
［27］ ZHANG ZW,SHEN LH,FU FM,et al.Clinical significance of procalcitonin in patients with chemotherapy-induced neutropenia and fever［J］.Chinese Journal of Cancer,2016,26(3):263-267.［张忠伟,申丽华,傅凤鸣,等.降钙素原在化疗致粒细胞减少伴发热患者中的临床意义［J］.中国癌症杂志,2016,26(3):263-267.］
［28］ Murat Sedef A,Kose F,Taner Sumbul A,et al.Prognostic value of procalcitonin in infection-related mortality of cancer patients［J］.Journal of BUON:Official Journal of Balkan Union of Oncology,2016,21(3):740-744.
［29］ ZHANG H,ZHOU WB,ALMS.The differential significance of procalcitonin and C-reactive protein in patients with malignant tumor fever［J］.Journal of The Central University for Nationalities(Natural Sciences),2016,25(02):68-70.［张华，周文斌，阿里穆斯.降钙素原与C-反应蛋白在恶性肿瘤发热患者中的鉴别意义［J］.中央民族大学学报(自然科学版),2016,25(02):68-70.］
［30］ QIAN X,MA JF.Clinical value of combined detection of serum procalcitonin and C-reactive protein in the diagnosis of early infection in patients with malignant tumors［J］.Chinese Journal of Laboratory Diagnosis,2017,21(03):399-402.［钱香，马建锋.血清降钙素原与C-反应蛋白联合检测对恶性肿瘤患者早期感染诊断的临床价值［J］.中国实验诊断学,2017,21(03):399-402.］
［31］ WANG Y,TONG FZ,TONG J,et al.The application value of procalcitonin,hypersensitive C-reactive protein and white blood cell count in the diagnosis of malignant tumor with infection［J］.Contemporary Medicine,2017,23(33):41-43.［王岩，佟凤芝，佟静，等.降钙素原、超敏C反应蛋白、白细胞数在恶性肿瘤伴感染诊断中的应用价值［J］.当代医学,2017,23(33):41-43.］